Correlation Between Pharma Mar and Atrys Health

Can any of the company-specific risk be diversified away by investing in both Pharma Mar and Atrys Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma Mar and Atrys Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharma Mar SA and Atrys Health SL, you can compare the effects of market volatilities on Pharma Mar and Atrys Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma Mar with a short position of Atrys Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma Mar and Atrys Health.

Diversification Opportunities for Pharma Mar and Atrys Health

0.95

Correlation Coefficient

Pharma Mar  Atrys Health

Almost no diversification

The 3 months correlation between Pharma and Atrys is 0.95. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Mar SA and Atrys Health SL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atrys Health SL and Pharma Mar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Mar SA are associated (or correlated) with Atrys Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atrys Health SL has no effect on the direction of Pharma Mar i.e., Pharma Mar and Atrys Health go up and down completely randomly.

Pair Corralation between Pharma Mar and Atrys Health

Assuming the 90 days trading horizon Pharma Mar SA is expected to under-perform the Atrys Health. In addition to that, Pharma Mar is 1.36 times more volatile than Atrys Health SL. It trades about -0.12 of its total potential returns per unit of risk. Atrys Health SL is currently generating about -0.15 per unit of volatility. If you would invest  356.00  in Atrys Health SL on February 17, 2025 and sell it today you would lose (68.00) from holding Atrys Health SL or give up 19.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Pharma Mar SA  vs.  Atrys Health SL

Pharma Mar SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharma Mar SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in June 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Atrys Health SL

Risk-Adjusted Performance

Very Weak

Over the last 90 days Atrys Health SL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in June 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Pharma Mar and Atrys Health

The main advantage of trading using opposite Pharma Mar and Atrys Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma Mar position performs unexpectedly, Atrys Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atrys Health will offset losses from the drop in Atrys Health's long position.

The idea behind Pharma Mar SA and Atrys Health SL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.